In an exclusive interview with MedPage Today in January -- as the cancer society was poised to name its next CEO to replace the retiring John Seffrin, PhD -- DeVita talked about his reasoning behind making that suggestion, the Societys ongoing transformation plan, and reflected on what has happened in the intervening 12 months. Topping his list of concerns is the ACSs traditional commitment to funding research explaining that that in 1945 Mary Lasker wanted 25% of all monies raised by ACS to go to research, a goal that is consistently missed. When I joined the Board funding for external research grants was 22% and when I left it was down to 10%, he said, a situation he called scandalous, especially since ACS has presented itself to the grassroots public as a research organization while putting its money into other projects. medpagetoday/HematologyOncology/OtherCancers/49710
Posted on: Mon, 26 Jan 2015 13:24:32 +0000
Trending Topics
Recently Viewed Topics
© 2015